share_log

Black Diamond Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. Rowe Price Investment Management, Inc.(19.0%)

Black Diamond Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. Rowe Price Investment Management, Inc.(19.0%)

美股SEC公告 ·  11/14 13:34
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息